Transform
Bluelight Crew
- Joined
- Sep 5, 2010
- Messages
- 4,791
Perhaps this will be of some use to you: http://i54.tinypic.com/2s1naf5.jpg
They are hard to differentiate unfortunately.
They are hard to differentiate unfortunately.
I was thinking of playing some instrumental stuff like explosions in the sky.
I can't see the point in large doses of this. I tried 15mg, and it was perfect. As in, I felt perfect for the duration. It was like dying, in a very good way.
As I've said before in the social thread, I tried 25mg and was making whale noises into the floor for half an hour xD. Thing is, I can't remember it. And none of my friends can remember their experiences on what must have been 'breakthroughs'. This confuses me. My experience on 25mg must have been intense... but it was pointless. Last thing I remember was my vision, of the pipe, just shattering, and then the next thing I'm aware of is being sat on the floor in a different room.
Anybody else experience these blackouts?
I think I might finally sample some of my 5-meo-dmt for the first time tomorrow. I got some fresh oil burners so I wont have to worry about any resin from other chems contaminating my trip. What is the best way to inhale it. Should I hold the flame under the bubble until I see vapor swirling around the inside and gently breath in. Thinking about starting with maybe 8-10mg. Would that be ok for a first timer that is very experienced with other psychedelics? Is this drug good with music or is silence better? I was thinking of playing some instrumental stuff like explosions in the sky.
solipsis said:I wonder how it combines with MXE, there could be problems since 5-MeO-DMT can be a strong drug physically (apparently much more dangerous with MAOIs than N,N-DMT for example) and MXE does not play well with everything.
I thought you said heavenliness for a second, which is what I got from 5-MeO-DMT sans the fear, body load or vomiting. But I insufflated it (sometimes with ketamine) and did not go extremely high...
My sterile vials arrived this week, so as soon as I get some filters and syringes I will be preparing a solution by making the citrate, to use for I.M.
Hopefully it will be very efficient that way and relatively gentle, at least less messy than snorting or smoking considering I don't mind injecting anymore since my K days.
I wonder how it combines with MXE, there could be problems since 5-MeO-DMT can be a strong drug physically (apparently much more dangerous with MAOIs than N,N-DMT for example) and MXE does not play well with everything.
5-MEO-DMT is like turning into the static on an old broken TV.
Thank you for that info solipsis!! I thank I have everythang you have listed I may just have to.give this a shot tomorow. Thanks again
5-MeO-DMT is a newer designer drug belonging to a group of naturally occurring indolealkylamines. Our recent study has demonstrated that coadministration of monoamine oxidase A (MAO-A) inhibitor harmaline (5 mg/kg) increases systemic exposure to 5-MeO-DMT (2 mg/kg) and active metabolite bufotenine.
This study is aimed at delineating harmaline and 5-MeO-DMT pharmacokinetic (PK) interactions at multiple dose levels, as well as the impact of (CYP2D6) that affects harmaline PK and determines 5-MeO-DMT O-demethylation to produce bufotenine. Our data revealed that inhibition of MAO-A-mediated metabolic elimination by harmaline (2, 5 and 15 mg/kg) led to a sharp increase in systemic and cerebral exposure to 5-MeO-DMT (2 and 10 mg/kg) at all dose combinations. A more pronounced effect on 5-MeO-DMT PK was associated with greater exposure to harmaline in wild-type mice than CYP2D6-humanized (Tg-CYP2D6) mice.
Harmaline (5 mg/kg) also increased blood and brain bufotenine concentrations that were generally higher in Tg-CYP2D6 mice. Surprisingly, greater harmaline dose (15 mg/kg) reduced bufotenine levels. The in vivo inhibitory effect of harmaline on CYP2D6-catalyzed bufotenine formation was confirmed by in vitro study using purified CYP2D6. Given these findings, a unified PK model including the inhibition of MAO-A- and CYP2D6-catalyzed 5-MeO-DMT metabolism by harmaline was developed to describe blood harmaline, 5-MeO-DMT and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models. This PK model may be further employed to predict harmaline and 5-MeO-DMT PK interactions at various doses, define the impact of CYP2D6 status, and drive harmaline-5-MeO-DMT pharmacodynamics.
Did you check if nothing was left behind, in the filter for example?
Thanks for letting me know so that I can skip trying it on microscale and proceeding with maybe 50 or 100 mg first with 5-MeO-DMT then also synthetic DMT.
Then after those trials I am probably going to make it a nice evening with MXE